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R127additional pieces in the collective cell
migration puzzle. As collective
epithelial cell migration is an integral
part of development and cancer
progression, further advances in the
area will aid our understanding and
could ultimately lead to improved
treatment of developmental diseases
and cancer.
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Predicts Autism’s EmergenceA new study has found that neural sensitivity to eye gaze in early infancy is
associated with subsequent development of autism. This discovery provides
a much-needed biomarker for autism spectrum disorder prior to emergence of
behavioral symptoms.Kevin A. Pelphrey
and James C. McPartland
Autism spectrum disorder (ASD) is
a common, early-onset
neurodevelopmental disorder
characterized by difficulties in social
interaction and communication and
repetitive or restricted interests and
behaviors [1]. ASD displays great
phenotypic heterogeneity and
etiological diversity, but since its
original description, social dysfunction
has been its hallmark and unifying
feature [2]. This social dysfunction is
revealed by abnormalities in both
simple behaviors, such as sharing
gaze, and more complex social
behaviors, such as triadic attention
sharing. Anomalies of social
perception, unlike communication
problems or repetitive behaviors that
are present in numerous disorders
(such as anxiety or expressive
language impairment), are unique to
ASD and are documented acrosssensory modalities. Autism is
a developmental disorder; early deficits
derail subsequent experiences,
thereby canalizing development
towards more severe dysfunction and
creating sequelae in additional
domains of function. Consequently, the
lack of reliable predictors of the
condition during the first year of life has
been a major impediment to the
effective treatment of ASD. Without
early predictors and in the absence of
a firm diagnosis until behavioral
symptoms emerge, treatment is often
delayed for two or more years.
In response to the urgent need for
a sensitive and specific biomarker of
ASD, many research groups from
around the world have been intensely
studying patterns of infant
development. These studies have
involved prospective longitudinal
studies of infant siblings of children
with ASD. Such designs use
a comparison group of infant siblings
without familial risks (the low-riskgroup) to gather longitudinal
information about developmental
trajectories across the first three years
of life, followed by clinical diagnosis at
36 months. As recently reviewed by
Rogers [3], the behavioral work to date,
using measures such as eye-tracking
and social probes, has failed to detect
atypical social development in the first
months of life, instead portraying
‘‘autism as a disorder involving
symptoms across multiple domains
with a gradual onset that changes both
ongoing developmental rate and
established behavioral patterns across
the first 2–3 years of life’’.
The findings presented in this issue
of Current Biology by Elsabbagh and
colleagues [4] challenge this notion and
remind us that our ability to study
development is contingent upon the
power of our methods of inquiry. Their
provocative results suggest that
investigation at the neural systems
level may reveal distinctions
inaccessible to behavioral assays
alone. They tested the hypothesis that
neural sensitivity to eye gaze in early
infancy would predict development of
ASD in toddlerhood. The study
involved a prospective longitudinal
sample of infants at high familial risk for
ASD and a comparison group of infants
at low risk. The researchers recorded
electrophysiological brain responses
(event-related potentials; ERPs) while
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R1286–10 month-old infants viewed faces
with dynamic eye gaze directed either
towards them or away from them.
Approximately 18 to 30 months later,
these children were clinically evaluated
for the presence of an ASD. Strikingly,
neural responses to dynamic eye gaze
shifts during the first year predicted
clinical outcomes at 36 months,
despite similar patterns of gaze as
measured by eye tracking. The authors
[4] conclude that ERP responses to eye
gaze in the first year of life reflect
developmental processes leading to
the later emergence of ASD.
As the field strives for earlier
methods of detecting autistic
development, these remarkable
findings offer hope for future clinical
practice, suggesting the possibility of
non-invasive, brain-based screening
methods that could detect differences
prior to behavioral emergence. ERPs
are collected with the same technology
(electroencephalography) commonly
used in hospitals around the world for
universal auditory screening of
newborns; the infrastructure might
already be in place to implement
population-based screening in an
affordable and highly efficient manner
[5]. Of course, prior to realization of
such clinical benefits, it will be critical
to investigate the specificity of this
biomarker to autism, its presence in an
unselected, population-based sample,
and, most importantly, its viability in
individual patient data. Given historical
difficulty parsing heterogeneity in ASD,
these findings suggest the potential
power of systems neuroscience
approaches to identify meaningful
subtypes of ASD to inform treatment
and predicting outcome. We envisiona strategy of deep behavior and brain
phenotyping over longitudinal
development to offer a detailed profile
of brain–behavior performance for
a given individual for the purpose of
detection of atypical development,
subcategorization (for example, for
genetic analysis), treatment selection,
and prediction of treatment response.
There is an important historical
perspective to be noted here.
Elsabbagh and colleagues [4] focused
their analyses on the P1, N290 and
P400 components of the ERP signal,
components that are modulated in
a number of face perception tasks,
including tests of sensitivity to the
direction of eye gaze in infants as
young as four months [6]. Critically,
experiments from a number of
laboratories around the world have
identified these ERP components in
infants as precursors of the
well-established face-sensitive N170
component in adults [7]. Just over
sixteen years ago, in the Yale
Neuropsychology Laboratory, Gregory
McCarthy, Shlomo Bentin, and their
colleagues first described the ‘N170’:
while recording from scalp electrodes
in typically developing adult
volunteers, they discovered that
human faces and face parts (especially
the eyes) reliably evoked a negative
ERP at 172 ms (range 130–200 ms) that
they labeled the N170. This response
was absent from the ERPs elicited by
many other animate and inanimate
non-face objects, and was maximal
over occipitotemporal electrode sites.
This work, coupled with numerous
behavioral findings concerning
face-processing deficits in ASD, led
researchers (including an author of thisdispatch) to study the N170 in children,
adolescents, and adults with ASD [8].
This set of events, from the basic
science discovery of a neural signature
for face processing in the human brain
to its translation into a potential
biomarker for the emergence of ASD
represents the very finest in the
emerging field of translational
developmental social neuroscience.
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Checkpoint SignalingThe spindle checkpoint forms an intricate signaling circuit to sense unattached
kinetochores, to inhibit the anaphase-promoting complex/cyclosome (APC/C),
and to delay anaphase onset. Using clever genetic experiments in the budding
yeast, Lau and Murray define the endpoint of checkpoint signaling and provide
key mechanistic insights into checkpoint inhibition of APC/C.Xuelian Luo1,* and Hongtao Yu1,2,*
The spindle checkpoint is a cell-cycle
surveillance system that guardsagainst chromosome missegregation
in mitosis and meiosis [1,2].
Dysregulation of the spindle
checkpoint can result in aneuploidyand cancer predisposition. The
molecular dissection of this checkpoint
began two decades ago with yeast
genetic studies that identified Mad
(mitotic arrest deficient) and Bub
(budding uninhibited by benomyl)
proteins as key checkpoint
components [3,4]. Subsequent genetic,
biochemical, and structural studies in
multiple organisms from yeast to man
then delineated a general framework of
how the spindle checkpoint
operates [2,5].
In this framework, checkpoint
proteins are recruited to kinetochores
